Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Wen Ling Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-3313-1488; OpenAlex author ID A5103874296. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper

Papers 3

  1. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Co-author DOI 10.1038/s41598-017-05541-4↗
  2. VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress. Co-author DOI 10.1016/j.canlet.2015.12.031↗
  3. Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway. Co-author DOI 10.3892/ol.2016.4928↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muxing Kang · 3 shared papers, 2016–2017 · strength 0.19
  2. Yulian Wu · 3 shared papers, 2016–2017 · strength 0.19
  3. Wenjie Qin · 3 shared papers, 2016–2017 · strength 0.19
  4. Yuefeng Zhang · 1 shared paper, 2017 · strength 0.07
  5. Lantian Wang · 1 shared paper, 2017 · strength 0.07
  6. Chao Richard Li · 1 shared paper, 2016 · strength 0.07
  7. Qingqu Guo · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.